On the other hand, CRISPR/Cas9-edited CD96−/− human NK cells did not display significant alterations in IFN-γ and TNF-α production, degranulation, or cytotoxic activity following stimulation with the U261MG CD155+ GBM line, in contrast to other tumor cell lines used. This evidence concerns the gene TNF and glioblastoma.